These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Developmental regulation of flavin-containing monooxygenase (FMO) isoforms 1 and 2 in pregnant rabbit. Lee MY, Smiley S, Kadkhodayan S, Hines RN, Williams DE. Chem Biol Interact; 1995 Apr 28; 96(1):75-85. PubMed ID: 7720106 [Abstract] [Full Text] [Related]
23. Tissue- and species-dependent expression of multiple forms of mammalian microsomal flavin-containing monooxygenase. Tynes RE, Philpot RM. Mol Pharmacol; 1987 Jun 28; 31(6):569-74. PubMed ID: 3600601 [Abstract] [Full Text] [Related]
24. Flavin-containing monooxygenase (FMO)-dependent metabolism of methionine and evidence for FMO3 being the major FMO involved in methionine sulfoxidation in rabbit liver and kidney microsomes. Duescher RJ, Lawton MP, Philpot RM, Elfarra AA. J Biol Chem; 1994 Jul 01; 269(26):17525-30. PubMed ID: 8021260 [Abstract] [Full Text] [Related]
25. Alternative processing events in human FMO genes. Lattard V, Zhang J, Cashman JR. Mol Pharmacol; 2004 Jun 01; 65(6):1517-25. PubMed ID: 15155844 [Abstract] [Full Text] [Related]
26. Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity. Lemoine A, Williams DE, Cresteil T, Leroux JP. Mol Pharmacol; 1991 Aug 01; 40(2):211-7. PubMed ID: 1875908 [Abstract] [Full Text] [Related]
27. Suppression of flavin-containing monooxygenase by overproduced nitric oxide in rat liver. Park CS, Baek HM, Chung WG, Lee KH, Ryu SD, Cha YN. Mol Pharmacol; 1999 Sep 01; 56(3):507-14. PubMed ID: 10462538 [Abstract] [Full Text] [Related]
28. Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1. Kim YM, Ziegler DM. Drug Metab Dispos; 2000 Aug 01; 28(8):1003-6. PubMed ID: 10901713 [Abstract] [Full Text] [Related]
29. Identification of multiple rabbit flavin-containing monooxygenase form 1 (FMO1) gene promoters and observation of tissue-specific DNase I hypersensitive sites. Luo Z, Hines RN. Arch Biochem Biophys; 1996 Dec 15; 336(2):251-60. PubMed ID: 8954572 [Abstract] [Full Text] [Related]
30. Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomeline. Ring BJ, Wrighton SA, Aldridge SL, Hansen K, Haehner B, Shipley LA. Drug Metab Dispos; 1999 Oct 15; 27(10):1099-103. PubMed ID: 10497134 [Abstract] [Full Text] [Related]
31. Localization of human flavin-containing monooxygenase genes FMO2 and FMO5 to chromosome 1q. McCombie RR, Dolphin CT, Povey S, Phillips IR, Shephard EA. Genomics; 1996 Jun 15; 34(3):426-9. PubMed ID: 8786146 [Abstract] [Full Text] [Related]
32. Prochiral sulfides as in vitro probes for multiple forms of the flavin-containing monooxygenase. Rettie AE, Meier GP, Sadeque AJ. Chem Biol Interact; 1995 Apr 28; 96(1):3-15. PubMed ID: 7720102 [Abstract] [Full Text] [Related]
33. Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity. Can Demirdöğen B, Adali O. Cell Biochem Funct; 2005 Apr 28; 23(4):245-51. PubMed ID: 15473006 [Abstract] [Full Text] [Related]
34. In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation. Rodrigues AD, Kukulka MJ, Ferrero JL, Cashman JR. Drug Metab Dispos; 1995 Oct 28; 23(10):1143-52. PubMed ID: 8654204 [Abstract] [Full Text] [Related]
35. Induction of flavin-containing monooxygenase (FMO B) in rabbit lung and kidney by sex steroids and glucocorticoids. Lee MY, Clark JE, Williams DE. Arch Biochem Biophys; 1993 May 28; 302(2):332-6. PubMed ID: 8489238 [Abstract] [Full Text] [Related]
36. Catalytic activity and expression of two flavin-containing monooxygenases from Drosophila melanogaster. Scharf ME, Scharf DW, Bennett GW, Pittendrigh BR. Arch Insect Biochem Physiol; 2004 Sep 28; 57(1):28-39. PubMed ID: 15352153 [Abstract] [Full Text] [Related]
37. Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: immunochemical and kinetic evidence for FMO3 being the major catalyst. Krause RJ, Ripp SL, Sausen PJ, Overby LH, Philpot RM, Elfarra AA. Arch Biochem Biophys; 1996 Sep 01; 333(1):109-16. PubMed ID: 8806760 [Abstract] [Full Text] [Related]
38. Expression of CYP2A genes in rodent and human nasal mucosa. Su T, Sheng JJ, Lipinskas TW, Ding X. Drug Metab Dispos; 1996 Aug 01; 24(8):884-90. PubMed ID: 8869824 [Abstract] [Full Text] [Related]
39. Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomes. Pike MG, Mays DC, Macomber DW, Lipsky JJ. Drug Metab Dispos; 2001 Feb 01; 29(2):127-32. PubMed ID: 11159801 [Abstract] [Full Text] [Related]
40. The fmo genes of Caenorhabditis elegans and C. briggsae: characterisation, gene expression and comparative genomic analysis. Petalcorin MI, Joshua GW, Agapow PM, Dolphin CT. Gene; 2005 Feb 14; 346():83-96. PubMed ID: 15716098 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]